Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA: Cancer J Clin. 2025;75:1–45.

PubMed  Google Scholar 

Lenis AT, Lec PM, Chamie K. Bladder Cancer JAMA. 2020;324:1980–91.

CAS  PubMed  Google Scholar 

Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, et al. Bladder cancer treatment and survival: evaluating treatment and survival in the National cancer data base. BJU Int. 2014;114:719–26.

Article  PubMed  Google Scholar 

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng A-C, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-Term results in 1,054 patients. J Clin Oncol. 2001;41:3772–81.

Article  Google Scholar 

Holzbeierlein J, Bixler BR, Buckley DI, Chang SS, Holmes RS, James AC et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024). J Urol. 2024;101097JU0000000000003981.

Bruins HM, Veskimae E, Hernandez V, Imamura M, Neuberger MM, Dahm P, et al. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: A systematic review. Eur Urol. 2014;66:1065–77.

Article  PubMed  Google Scholar 

Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–66.

Article  CAS  PubMed  Google Scholar 

Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, et al. Neoadjuvant chemotherapy for Muscle-Invasive bladder cancer: A systematic review and Two‐Step Meta‐Analysis. Oncol. 2016;21:708–15.

Article  CAS  Google Scholar 

Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Lucianò R et al. Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. J Clin Oncol. 2018;36:JCO.18.01148.

Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55:164–76.

Article  PubMed  Google Scholar 

Quek ML, Stein JP, Daneshmand S, Miranda G, Thangathurai D, Roffey P, et al. A critical analysis of perioperative mortality from radical cystectomy. J Urol. 2006;175:886–90.

Article  PubMed  Google Scholar 

Grobet-Jeandin E, Lenfant L, Mir C, Giannarini G, Alcaraz A, Albersen M, et al. A systematic review of oncological outcomes associated with bladder-sparing strategies in patients achieving complete clinical response to initial systemic treatment for localized Muscle-invasive bladder cancer. Eur Urol Oncol. 2023;6:251–62.

Article  PubMed  Google Scholar 

Winoker JS, Liaw CW, Galsky MD, Wiklund P, Mehrazin R. Clinical complete response after neoadjuvant chemotherapy for Muscle-invasive bladder cancer: A call for standardized assessments and definitions. Eur Urol Focus. 2020;6:627–9.

Article  PubMed  Google Scholar 

Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, et al. Absence of tumor on repeat transurethral resection of bladder tumor does not predict final pathologic T0 stage in bladder cancer treated with radical cystectomy. Eur Urol Focus. 2018;4:720–4.

Article  PubMed  Google Scholar 

Becker REN, Meyer AR, Brant A, Reese AC, Biles MJ, Harris KT, et al. Clinical restaging and tumor sequencing are inaccurate indicators of response to neoadjuvant chemotherapy for Muscle-invasive bladder cancer. Eur Urol. 2021;79:364–71.

Article  CAS  PubMed  Google Scholar 

Zibelman M, Asghar AM, Parker DC, O’Neill J, Wei S, Greenberg RE, et al. Cystoscopy and systematic bladder tissue sampling in predicting pT0 bladder cancer: A prospective trial. J Urol. 2021;205:1605–11.

Article  PubMed  PubMed Central  Google Scholar 

Luo C, Huang B, Wu Y, Chen J, Chen L. Use of vesical Imaging-Reporting and data system (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis. Eur Radiol. 2020;30:4606–14.

Article  PubMed  Google Scholar 

Pecoraro M, Giudice FD, Magliocca F, Simone G, Flammia S, Leonardo C, et al. Vesical Imaging-Reporting and data system (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report. Abdom Radiol. 2022;47:763–70.

Article  Google Scholar 

Necchi A, Basile G, Gibb EA, Raggi D, Calareso G, de Padua TC, et al. Vesical Imaging-Reporting and data system use predicting the outcome of neoadjuvant pembrolizumab in muscle‐invasive bladder cancer. BJU Int. 2024;133:214–22.

Article  CAS  PubMed  Google Scholar 

Panebianco V, Briganti A, Boellaard TN, Catto J, Comperat E, Efstathiou J, et al. Clinical application of bladder MRI and the vesical Imaging-Reporting and data system. Nat Rev Urol. 2024;21:243–51.

Article  PubMed  Google Scholar 

Choi SJ, Park KJ, Heo C, Park BW, Kim M, Kim JK. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clin Radiol. 2021;76:e62713–21.

Article  Google Scholar 

Soubra A, Gencturk M, Froelich J, Balaji P, Gupta S, Jha G, et al. FDG-PET/CT for assessing the response to neoadjuvant chemotherapy in bladder cancer patients. Clin Genitourin Cancer. 2018;16:360–4.

Article  PubMed  Google Scholar 

Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus F-J, Bui VN, et al. Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma. Eur J Nucl Med Mol Imaging. 2022;49:3571–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Novruzov E, Dendl K, Ndlovu H, Choyke PL, Dabir M, Beu M, et al. Head-to-head Intra-individual comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in patients with bladder cancer. Mol Imaging Biol. 2022;24:651–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan X, Xia L, Zhang Z, Ren Y, Pomper MG, Rowe SP, et al. First-in-Human study of the radioligand 68Ga-N188 targeting Nectin-4 for PET/CT imaging of advanced urothelial carcinoma. Clin Cancer Res. 2023;29:3395–407.

Article  CAS  PubMed  Google Scholar 

ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/.

Raitanen M-P, Aine R, Rintala E, Kallio J, Rajala P, Juusela H, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol. 2002;41:284–9.

Article  PubMed  Google Scholar 

Palou J, Brausi M, Catto JWF. Management of patients with normal cystoscopy but positive cytology or urine markers. Eur Urol Oncol. 2020;3:548–54.

Article  PubMed  Google Scholar 

Gopalakrishna A, Fantony JJ, Longo TA, Owusu R, Foo W-C, Dash R, et al. Anticipatory positive urine tests for bladder cancer. Ann Surg Oncol. 2017;24:1747–53.

Article  PubMed  Google Scholar 

Birkenkamp-Demtröder K, Nordentoft I, Christensen E, Høyer S, Reinert T, Vang S, et al. Genomic alterations in liquid biopsies from patients with bladder cancer. Eur Urol. 2016;70:75–82.

Article  PubMed  Google Scholar 

Christensen E, Birkenkamp-Demtröder K, Sethi H, Shchegrova S, Salari R, Nordentoft I, et al. Early detection of metastatic relapse and monitoring of therapeutic efficacy by Ultra-Deep sequencing of plasma Cell-Free DNA in patients with urothelial bladder carcinoma. J Clin Oncol. 2019;37:JCO1802052.

Article  Google Scholar 

Birkenkamp-Demtröder K, Christensen E, Nordentoft I, Knudsen M, Taber A, Høyer S, et al. Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis. Eur Urol. 2018;73:535–40.

Article  PubMed  Google Scholar 

Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, et al. Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discov. 2018;9:CD–18.

Google Scholar 

Christensen E, Nordentoft I, Birkenkamp-Demtroder K, Elbæk SK, Lindskrog SV, Taber A, et al. Cell-free urine and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer. Clin Cancer Res. 2023;29:1582–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Satyal U, Valentine H, Liu D, Slifker M, Lallas CD, Trabulsi EJ, et al. Urine biopsy as dynamic biomarker to enhance clinical staging of bladder cancer in radical cystectomy candidates. JCO Precis Oncol. 2024;8:e2300362.

Article  PubMed  Google Scholar 

Powles T, Assaf ZJ, Degaonkar V, Grivas P, Hussain M, Oudard S, et al. Updated overall survival by Circulating tumor DNA status from the phase 3 IMvigor010 trial: adjuvant Atezolizumab versus observation in Muscle-invasive urothelial carcinoma. Eur Urol. 2024;85:114–22.

Article  CAS  PubMed